Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen To Present AMG 334 Data At 17th Congress of the International Headache Society

[PR Newswire] – THOUSAND OAKS, Calif., May 11, 2015 /PRNewswire/ — Amgen (AMGN) today announced it will be presenting data for its calcitonin gene-related peptide (CGRP) receptor inhibitor AMG 334 at the 17th . . . → Read More: Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen To Present AMG 334 Data At 17th Congress of the International Headache Society Similar Articles: Stock Update (NASDAQ:AMGN): U.S. FDA approves Amgen heart failure drug Stock Update (NASDAQ:AMGN): Amgen To Present At The Goldman Sachs Key Debates In Biosimilars Conference Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit